AN2 Therapeutics Inc (ANTX)

AN2 Therapeutics Inc (ANTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $166M; returns 1 day -2.5%, 1 week +5.0%, 1 year +203.4%.

AN2 Therapeutics, Inc. (ANTX) is a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its proprietary boron-based platform for treating rare infectious diseases and pulmonary arterial hypertension (PAH).

Groups ANTX belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Clinical Stage
• Infectious Diseases
• Rare Diseases
• Biopharmaceutical
• Life Sciences

ANTX financial model: income statement, cash flow and balance sheet